Life Years Saved

By | November 11th, 2015|Uncategorized|

We just recently published what we call a "population effectiveness model" in Value in Health, entitled "Estimated Life Years Saved in Women with HER2 Positive Metastatic Breast Cancer Receiving First-Line Trastuzumab and Pertuzumab In the United States". We estimated the life years saved due to metastatic HER2 positive breast cancer after the introduction of trastuzumab, [...]